Gout is a common type of inflammatory arthritis that occurs due to uric acid crystallisation and subsequent build-up in the ...

The refractory gout market is growing because of the rising prevalence of gout brought on by aging populations and changes in ...

Similarly, factors influencing doctors to improve the treatment of gout, including requests for urate levels in the intercritical period, and action to prescribe appropriate urate-lowering therapy ...

Gout flares are commonly underreported among U.S. adults with gout, according to a study published in the January issue of ...

Treatment for gout may include reducing your consumption of these offending foods. While it might be surprising to you, certain common medications can also increase uric acid and trigger gout ...

Research reveals groundbreaking results about Mounjaro and Ozempic in weight loss treatment. Here's what you need to know ...

XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...

Medscape Medical News, November 25, 2024 ACR 2024 Diabetes Drug Class May Reduce Need for Gout Medications Real-world data show reduction in use of urate-lowering therapy among people with type 2 ...

XORTX Therapeutics (XRTX) announces the launch of a new late stage program to treat gout. The new drug development program – XRx-026 – will ...

This lets uric acid accumulate, crystallize, and settle in the joints. Managing gout is possible with medications, lifestyle changes, and a gout-friendly diet. This article reviews the best diets ...

Gout is a painful condition affecting millions worldwide. The primary cause is the buildup of uric acid crystals in the joints, leading to inflammation and swelling. While there isn’t yet a ...

XORTX Therapeutics Inc. is a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. The company is actively involved in creating ...